Gonadotropin-releasing hormone agonist for preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.
Reproductive Endocrinology, Department of Obstetrics and Gynecology, Rambam Health Care Campus, Rappaport Institute, Technion-Faculty of Medicine, Bath-Galim, Haifa, Israel, 31096; .Journal of Clinical Oncology (Impact Factor: 18.04). 05/2012; 30(26):3310. DOI: 10.1200/JCO.2012.41.8467
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.